| The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphatidylinositol 3-kinase-dependent pathway. | None |
| The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts. | None |
| Inhibition of Akt kinase activity by a peptide spanning the betaA strand of the proto-oncogene TCL1. | None |
| Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity. | None |
| Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson s disease. | None |
| FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. | None |
| Proto-oncogene TCL1: more than just a coactivator for Akt. | None |
| KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway. | None |
| Ang1 protects cardiomyocytes from oxidative stress-induced apoptosis by regulating the activity of Proto-Oncogene Proteins c-akt | None |
| a subpopulation of Akt is cholesterol sensitive and the oncogenic effects conferred by myristoylation arise, in part, from the tendency of the membrane-targeted form of the protein to reside in cholesterol-rich membrane microdomains | None |
| Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. | None |
| Dopamine Transporter-related reduction of extracellular dopamine levels appears to be selectively affecting the D2 receptor-mediated signaling pathway as evidenced by an increase in the basal phosphorylation state of Proto-Oncogene Proteins c-akt. | None |
| Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. | None |
| CDC37 in concert with HSP90 plays an essential role in maintaining oncogenic protein kinase clients including ERBB2, CRAF, CDK4, CDK6, & phosphorylated AKT. | None |
| Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain. | None |
| The prostaglandin E2 receptor, EP4 subunit genetic deficiency in macrophages suppresses the Pik3ap1 protein/Proto-Oncogene Proteins c-akt signaling pathway, reducing activation of bcl-associated Death protein, which results in increased apoptosis. | None |
| Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis | None |
| Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. | None |
| The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt. | None |
| Phosphatidylinositol 4,5-bisphosphate-specific AKT1 is oncogenic. | None |